Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation

Journal of Biochemistry

Volumn 150, Issue 2, 2011, Pages 127-132

  Suzuki Inoue, Katsue ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

CLEC 2; lymphangiogenesis; platelets; podoplanin; tumour metastasis

Indexed keywords

C TYPE LECTIN LIKE RECEPTOR 2; LECTIN RECEPTOR; PODOPLANIN; SNAKE VENOM; UNCLASSIFIED DRUG;

BLEEDING; BLOOD VESSEL; IN VIVO STUDY; LYMPHANGIOGENESIS; METASTASIS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOGENESIS; TUMOR CELL;

ANIMALS; BLOOD PLATELETS; HUMANS; LECTINS, C-TYPE; LYMPHANGIOGENESIS; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASM METASTASIS; NEOPLASMS; PLATELET ACTIVATION; PLATELET AGGREGATION; SIGNAL TRANSDUCTION; THROMBOSIS; VIPER VENOMS;

MUS;

EID: 79961052353     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvr079     Document Type: Review

References (50)

1. Huang, T.F., Liu, C.Z., and Yang, S.H. (1995) Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist. Biochem. J. 309 (Pt 3), 1021-1027
2. Shin, Y. and Morita, T. (1998) Rhodocytin, a functional novel platelet agonist belonging to the heterodimeric C-type lectin family, induces platelet aggregation independently of glycoprotein Ib. Biochem. Biophys. Res. Commun. 245, 741-745 (Pubitemid 28413988)
3. Inoue, K., Ozaki, Y., Satoh, K., Wu, Y., Yatomi, Y., Shin, Y., and Morita, T. (1999) Signal transduction pathways mediated by glycoprotein Ia/IIa in human platelets: Comparison with those of glycoprotein VI. Biochem. Biophys. Res. Commun. 256, 114-120 (Pubitemid 29298927)
4. Suzuki-Inoue, K., Ozaki, Y., Kainoh, M., Shin, Y., Wu, Y., Yatomi, Y., Ohmori, T., Tanaka, T., Satoh, K., and Morita, T. (2001) Rhodocytin induces platelet aggregation by interacting with glycoprotein Ia/IIa (GPIa/IIa, Integrin alpha 2beta 1). Involvement of GPIa/ IIa-associated src and protein tyrosine phosphorylation. J. Biol. Chem. 276, 1643-1652 (Pubitemid 32096601)
5. Navdaev, A., Clemetson, J.M., Polgar, J., Kehrel, B.E., Glauner, M., Magnenat, E., Wells, T.N., and Clemetson, K.J. (2001) Aggretin, a heterodimeric C-type lectin from Calloselasma rhodostoma (malayan pit viper), stimulates platelets by binding to alpha 2beta 1 integrin and glycoprotein Ib, activating Syk and phospholipase Cgamma 2, but does not involve the glycoprotein VI/Fc receptor gamma chain collagen receptor. J. Biol. Chem. 276, 20882-20889
6. Bergmeier, W., Bouvard, D., Eble, J.A., Mokhtari- Nejad, R., Schulte, V., Zirngibl, H., Brakebusch, C., Fassler, R., and Nieswandt, B. (2001) Rhodocytin (aggretin) activates platelets lacking alpha(2)beta(1) integrin, glycoprotein VI, and the ligand-binding domain of glycoprotein Ibalpha. J. Biol. Chem. 276, 25121-25126
7. Suzuki-Inoue, K., Fuller, G.L., Garcia, A., Eble, J.A., Pohlmann, S., Inoue, O., Gartner, T.K., Hughan, S.C., Pearce, A.C., Laing, G.D., Theakston, R.D., Schweighoffer, E., Zitzmann, N., Morita, T., Tybulewicz, V.L., Ozaki, Y., and Watson, S.P. (2006) A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 107, 542-549 (Pubitemid 43076377)
8. Colonna, M., Samaridis, J., and Angman, L. (2000) Molecular characterization of two novel C-type lectin-like receptors, one of which is selectively expressed in human dendritic cells. Eur. J. Immunol. 30, 697-704 (Pubitemid 30098866)
9. Chaipan, C., Soilleux, E.J., Simpson, P., Hofmann, H., Gramberg, T., Marzi, A., Geier, M., Stewart, E.A., Eisemann, J., Steinkasserer, A., Suzuki-Inoue, K., Fuller, G.L., Pearce, A.C., Watson, S.P., Hoxie, J.A., Baribaud, F., and Pohlmann, S. (2006) DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J. Virol. 80, 8951-8960 (Pubitemid 44359969)
10. Tang, T., Li, L., Tang, J., Li, Y., Lin, W.Y., Martin, F., Grant, D., Solloway, M., Parker, L., Ye, W., Forrest, W., Ghilardi, N., Oravecz, T., Platt, K.A., Rice, D.S., Hansen, G.M., Abuin, A., Eberhart, D.E., Godowski, P., Holt, K.H., Peterson, A., Zambrowicz, B.P., and de Sauvage, F.J. (2010) A mouse knockout library for secreted and transmembrane proteins. Nat. Biotechnol. 28, 749-755
11. Kerrigan, A.M., Dennehy, K.M., Mourao-Sa, D., Faro- Trindade, I., Willment, J.A., Taylor, P.R., Eble, J.A., Reis e Sousa, C., and Brown, G.D. (2009) CLEC-2 is a phagocytic activation receptor expressed on murine peripheral blood neutrophils. J. Immunol. 182, 4150-4157
12. Chang, C.H., Chung, C.H., Hsu, C.C., Huang, T.Y., and Huang, T.F. (2010) A novel mechanism of cytokine release in phagocytes induced by aggretin, a snake venom C-type lectin protein, through CLEC-2 ligation. J. Thromb. Haemost. 8, 2563-2570
13. Watson, S.P., Auger, J.M., McCarty, O.J., and Pearce, A.C. (2005) GPVI and integrin alphaIIb beta3 signaling in platelets. J. Thromb. Haemost. 3, 1752-1762 (Pubitemid 41716562)
14. Fuller, G.L., Williams, J.A., Tomlinson, M.G., Eble, J.A., Hanna, S.L., Pohlmann, S., Suzuki-Inoue, K., Ozaki, Y., Watson, S.P., and Pearce, A.C. (2007) The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade. J. Biol. Chem. 282, 12397-12409 (Pubitemid 47100620)
15. Watson, A.A., Christou, C.M., James, J.R., Fenton- May, A.E., Moncayo, G.E., Mistry, A.R., Davis, S.J., Gilbert, R.J., Chakera, A., and O'Callaghan, C.A. (2009) The platelet receptor CLEC-2 is active as a dimer. Biochemistry 48, 10988-10996
16. Hughes, C.E., Pollitt, A.Y., Mori, J., Eble, J.A., Tomlinson, M.G., Hartwig, J.H., O'Callaghan, C.A., Futterer, K., and Watson, S.P. (2010) CLEC-2 activates Syk through dimerization. Blood 115, 2947-2955
17. Ezumi, Y., Shindoh, K., Tsuji, M., and Takayama, H. (1998) Physical and functional association of the Src family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fc receptor gamma chain complex on human platelets. J. Exp. Med. 188, 267-276 (Pubitemid 28357755)
18. Suzuki-Inoue, K., Tulasne, D., Shen, Y., Bori-Sanz, T., Inoue, O., Jung, S.M., Moroi, M., Andrews, R.K., Berndt, M.C., and Watson, S.P. (2002) Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling. J. Biol. Chem. 277, 21561-21566 (Pubitemid 34952302)
19. Spalton, J.C., Mori, J., Pollitt, A.Y., Hughes, C.E., Eble, J.A., and Watson, S.P. (2009) The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets. J. Thromb. Haemost. 7, 1192-1199
20. Nash, G.F., Turner, L.F., Scully, M.F., and Kakkar, A.K. (2002) Platelets and cancer. Lancet Oncol. 3, 425-430 (Pubitemid 36958273)
21. Katagiri, Y., Hayashi, Y., Baba, I., Suzuki, H., Tanoue, K., and Yamazaki, H. (1991) Characterization of platelet aggregation induced by the human melanoma cell line HMV-I: Roles of heparin, plasma adhesive proteins, and tumor cell membrane proteins. Cancer Res. 51, 1286-1293
22. Kitagawa, H., Yamamoto, N., Yamamoto, K., Tanoue, K., Kosaki, G., and Yamazaki, H. (1989) Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/ IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells. Cancer Res. 49, 537-541 (Pubitemid 19050310)
23. Kato, Y., Fujita, N., Kunita, A., Sato, S., Kaneko, M., Osawa, M., and Tsuruo, T. (2003) Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors. J. Biol. Chem. 278, 51599-51605 (Pubitemid 38020404)
24. Nieswandt, B., Hafner, M., Echtenacher, B., and Mannel, D.N. (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 59, 1295-1300 (Pubitemid 29136261)
25. Schacht, V., Dadras, S.S., Johnson, L.A., Jackson, D.G., Hong, Y.K., and Detmar, M. (2005) Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am. J. Pathol. 166, 913-921 (Pubitemid 40315647)
26. Kato, Y., Kaneko, M., Sata, M., Fujita, N., Tsuruo, T., and Osawa, M. (2005) Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma. Tumour Biol. 26, 195-200 (Pubitemid 41379745)
27. Kato, Y., Sasagawa, I., Kaneko, M., Osawa, M., Fujita, N., and Tsuruo, T. (2004) Aggrus: A diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors. Oncogene 23, 8552-8556 (Pubitemid 39540806)
28. Mishima, K., Kato, Y., Kaneko, M.K., Nishikawa, R., Hirose, T., and Matsutani, M. (2006) Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression. Acta Neuropathol. 111, 483-488
29. Mishima, K., Kato, Y., Kaneko, M.K., Nakazawa, Y., Kunita, A., Fujita, N., Tsuruo, T., Nishikawa, R., Hirose, T., and Matsutani, M. (2006) Podoplanin expression in primary central nervous system germ cell tumors: A useful histological marker for the diagnosis of germinoma. Acta Neuropathol. 111, 563-568 (Pubitemid 43778961)
30. Kato, Y., Kaneko, M.K., Kuno, A., Uchiyama, N., Amano, K., Chiba, Y., Hasegawa, Y., Hirabayashi, J., Narimatsu, H., Mishima, K., and Osawa, M. (2006) Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain. Biochem. Biophys. Res. Commun. 349, 1301-1307 (Pubitemid 44416399)
31. Tsuruo, T. and Fujita, N. (2008) Platelet aggregation in the formation of tumor metastasis. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 84, 189-198 (Pubitemid 351847103)
32. Yuan, P., Temam, S., El-Naggar, A., Zhou, X., Liu, D.D., Lee, J.J., and Mao, L. (2006) Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer 107, 563-569 (Pubitemid 44107217)
33. Suzuki-Inoue, K., Kato, Y., Inoue, O., Kaneko, M.K., Mishima, K., Yatomi, Y., Yamazaki, Y., Narimatsu, H., and Ozaki, Y. (2007) Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J. Biol. Chem. 282, 25993-26001 (Pubitemid 47443800)
34. Christou, C.M., Pearce, A.C., Watson, A.A., Mistry, A.R., Pollitt, A.Y., Fenton-May, A.E., Johnson, L.A., Jackson, D.G., Watson, S.P., and O'Callaghan, C.A. (2008) Renal cells activate the platelet receptor CLEC-2 through podoplanin. Biochem. J. 411, 133-140 (Pubitemid 351482355)
35. Kato, Y., Kaneko, M.K., Kunita, A., Ito, H., Kameyama, A., Ogasawara, S., Matsuura, N., Hasegawa, Y., Suzuki-Inoue, K., Inoue, O., Ozaki, Y., and Narimatsu, H. (2008) Molecular analysis of the pathophysiological binding of the platelet aggregationinducing factor podoplanin to the C-type lectin-like receptor CLEC-2. Cancer Sci. 99, 54-61 (Pubitemid 350239031)
36. Tammela, T. and Alitalo, K. (2010) Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140, 460-476
37. Abtahian, F., Guerriero, A., Sebzda, E., Lu, M.M., Zhou, R., Mocsai, A., Myers, E.E., Huang, B., Jackson, D.G., Ferrari, V.A., Tybulewicz, V., Lowell, C.A., Lepore, J.J., Koretzky, G.A., and Kahn, M.L. (2003) Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 299, 247-251 (Pubitemid 36125210)
38. Schacht, V., Ramirez, M.I., Hong, Y.K., Hirakawa, S., Feng, D., Harvey, N., Williams, M., Dvorak, A.M., Dvorak, H.F., Oliver, G., and Detmar, M. (2003) T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22, 3546-3556 (Pubitemid 36898332)
39. Uhrin, P., Zaujec, J., Breuss, J.M., Olcaydu, D., Chrenek, P., Stockinger, H., Fuertbauer, E., Moser, M., Haiko, P., Fassler, R., Alitalo, K., Binder, B.R., and Kerjaschki, D. (2010) Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 115, 3997-4005
40. Johnson, N.C., Dillard, M.E., Baluk, P., McDonald, D.M., Harvey, N.L., Frase, S.L., and Oliver, G. (2008) Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev. 22, 3282-3291
41. Fu, J., Gerhardt, H., McDaniel, J.M., Xia, B., Liu, X., Ivanciu, L., Ny, A., Hermans, K., Silasi-Mansat, R., McGee, S., Nye, E., Ju, T., Ramirez, M.I., Carmeliet, P., Cummings, R.D., Lupu, F., and Xia, L. (2008) Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J. Clin. Invest. 118, 3725-3737
42. Carramolino, L., Fuentes, J., Garcia-Andres, C., Azcoitia, V., Riethmacher, D., and Torres, M. (2010) Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis. Circ. Res. 106, 1197-1201
43. Bertozzi, C.C., Schmaier, A.A., Mericko, P., Hess, P.R., Zou, Z., Chen, M., Chen, C.Y., Xu, B., Lu, M.M., Zhou, D., Sebzda, E., Santore, M.T., Merianos, D.J., Stadtfeld, M., Flake, A.W., Graf, T., Skoda, R., Maltzman, J.S., Koretzky, G.A., and Kahn, M.L. (2010) Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 116, 661-670
44. Suzuki-Inoue, K., Inoue, O., Ding, G., Nishimura, S., Hokamura, K., Eto, K., Kashiwagi, H., Tomiyama, Y., Yatomi, Y., Umemura, K., Shin, Y., Hirashima, M., and Ozaki, Y. (2010) Essential in vivo roles of the C-type lectin receptor CLEC-2: Embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J. Biol. Chem. 285, 24494-24507
45. Moser, M., Nieswandt, B., Ussar, S., Pozgajova, M., and Fassler, R. (2008) Kindlin-3 is essential for integrin activation and platelet aggregation. Nat. Med. 14, 325-330 (Pubitemid 351347914)
46. Backhed, F., Crawford, P.A., O'Donnell, D., and Gordon, J.I. (2007) Postnatal lymphatic partitioning from the blood vasculature in the small intestine requires fasting-induced adipose factor. Proc. Natl Acad. Sci. USA 104, 606-611 (Pubitemid 46123072)
47. Taniguchi, K., Kohno, R., Ayada, T., Kato, R., Ichiyama, K., Morisada, T., Oike, Y., Yonemitsu, Y., Maehara, Y., and Yoshimura, A. (2007) Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling. Mol. Cell. Biol. 27, 4541-4550 (Pubitemid 46906575)
48. May, F., Hagedorn, I., Pleines, I., Bender, M., Vogtle, T., Eble, J., Elvers, M., and Nieswandt, B. (2009) CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis. Blood 114, 3464-3472
49. Cambien, B., Bergmeier, W., Saffaripour, S., Mitchell, H.A., and Wagner, D.D. (2003) Antithrombotic activity of TNF-alpha. J. Clin. Invest. 112, 1589-1596
50. Hughes, C.E., Navarro-Nunez, L., Finney, B.A., Mourao-Sa, D., Pollitt, A.Y., and Watson, S.P. (2010) CLEC-2 is not required for platelet aggregation at arteriolar shear. J. Thromb. Haemost. 8, 2328-2332